Elamipretidedosage The ss-31 peptide elamipretide mechanism is a subject of intense scientific interest, primarily due to its potent ability to target and modulate mitochondrial function2016年10月20日—Elamipretideis a mitochondrial cardiolipin binderused to improve muscle strength in patients with Barth syndrome.. This peptide, also known by its development codes SS-31, MTP-131, and brand names like Bendavia and Forzinity, is a synthetic tetrapeptide composed of D-Arg- dimethyl-Tyr-Lys-Phe-NH2SS-31 Peptide | Cellular Energy & Repair. Its unique structure and targeted action have positioned it as a promising therapeutic agent for a range of conditions characterized by mitochondrial dysfunction.
At the core of elamipretide's efficacy lies its profound interaction with the inner mitochondrial membrane作者:S Russo·2024·被引用次数:20—We found that in vivo treatment of Taz KD mice with a CL-targeted smallpeptide(namedSS-31) was able to restore mitochondrial morphology in tafazzin- .... Research indicates that elamipretide selectively accumulates within the inner mitochondrial membrane, where it exerts its beneficial effects. A key aspect of its mechanism of action involves its interaction with cardiolipin, a unique phospholipid crucial for mitochondrial structure and function. SS-31's mechanism of action lies in its targeted interaction with cardiolipin, which is a vital component of the inner mitochondrial membrane作者:YA Chiao·2020·被引用次数:130—We show here that 8-week treatment of old mice with the mitochondrial targetedpeptide SS-31(elamipretide) can substantially reverse this deficit.. This interaction is characterized by high affinity binding to cardiolipin molecules, effectively preventing their peroxidation and degradation. This protective action is fundamental to preserving the integrity and function of the mitochondria.
Further insights into the ss-31 peptide elamipretide mechanism reveal its ability to bind lipid bilayers and modulate surface electrostatics. Studies have demonstrated that SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action. This interaction is largely driven by the negative surface charge of mitochondrial membranes, and in turn, SS-31 alters lipid bilayer properties.作者:W Mitchell·2019·被引用次数:5—Our results show thatSS-31membrane interaction is driven largely by the negative surface charge of mitochondrial membranes and thatSS-31... This modulation of the mitochondrial membrane environment is critical for maintaining optimal mitochondrial respiration and energy production.
The therapeutic implications of this targeted approach are significant. By directly enhancing mitochondrial function, elamipretide has shown promise in improving cellular energy production. For instance, studies have shown that SS-31 (Elamipretide) is a targeted mitochondrial peptide that restores ATP production and reduces oxidative stress at the cellular level. This restoration of mitochondrial health is particularly relevant in conditions associated with aging and disease. Research has indicated that SS-31 is a peptide that plays an integral role in mitochondrial repair that becomes necessary as we age. In aged mice, for example, SS-31 treatment has been shown to substantially reverse deficits in mitochondrial function. Furthermore, elamipretide has demonstrated the capacity to improve ADP sensitivity in aged mitochondria by increasing uptake through the adenine nucleotide transporter.
Beyond its direct impact on mitochondrial energetics, the elamipretide mechanism also extends to broader cellular protective effectsSS-31 (also known as Bendavia, Elamipretide, and MTP-131)is a small peptide (D-Arg- dimethyl-Tyr-Lys-Phe-NH2) that accumulates in mitochondria and .... It is recognized as a novel mitochondria-targeted peptide antioxidant that reduces mitochondrial reactive oxygen species production. This antioxidant capacity contributes to its protective effects against various forms of cellular damage. Notably, the BDNF pathway is involved in the protective effects of SS-31 on isoflurane-induced cognitive deficits in aging mice, highlighting its potential neuroprotective capabilities.Elamipretide - an overview | ScienceDirect Topics
The therapeutic potential of elamipretide is being explored in several clinical contextsElamipretide – Knowledge and References. It is recognized as a medication used for the treatment of Barth syndrome, a rare genetic disorder affecting mitochondrial function. Its ability to target mitochondria directly makes it a valuable peptide for addressing conditions where mitochondrial dysfunction is a primary driver of pathology. The elamipretide peptide readily penetrates cell membranes, further enhancing its therapeutic reach.2016年10月20日—Elamipretideis a mitochondrial cardiolipin binderused to improve muscle strength in patients with Barth syndrome.
In summary, the ss-31 peptide elamipretide mechanism is multifaceted, revolving around its precise targeting of the inner mitochondrial membrane and its interaction with cardiolipin. This interaction leads to the stabilization of the mitochondrial membrane, preservation of cardiolipin, enhanced ATP production, and reduction of oxidative stressMolecular Mechanism of Action of Mitochondrial .... As a mitochondria-targeted peptide, elamipretide represents a significant advancement in the development of therapies aimed at restoring mitochondrial health and combating age-related and disease-induced cellular decline. The detailed understanding of its mechanisms continues to pave the way for its expanded clinical applications.Discovery of novel SS-31 ( d -Arg-dimethylTyr-Lys-Phe-NH 2 ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.